VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
FBRX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
FBRXForte Biosciences, Inc.
$22.25$4.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksFBRXQuarterly Balance Sheet

Forte Biosciences, Inc. (FBRX) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

Forte Biosciences, Inc. (FBRX) quarterly balance sheet — complete assets, liabilities & equity history

FBRX Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Total Current Assets65.11M80.59M95.41M107.62M47.16M61.35M17.67M25.71M31.5M38.33M47.1M30.75M36.27M41.51M44.59M38.85M40.41M42.52M46.56M51.88M
Cash & Short-Term Investments58.22M76.96M93.41M106.14M45.86M58.37M16.36M24.5M30.44M37.13M46.19M30.43M35.9M41.1M44.05M38.55M40.03M42.04M45.66M50.8M
Cash Only58.22M76.96M93.41M106.14M45.86M22.24M16.36M24.5M10.63M11.96M21.14M20.44M35.9M41.1M44.05M38.55M40.03M42.04M45.66M50.8M
Short-Term Investments0000036.12M0019.81M25.16M25.04M9.99M00000000
Accounts Receivable0817K527K00000000000000000
Days Sales Outstanding--------------------
Inventory00000000000000000000
Days Inventory Outstanding--------------------
Other Current Assets6.89M2.81M1.47M588K449K336K274K313K233K165K94K129K109K70K119K94K89K89K119K139K
Total Non-Current Assets2.11M2.19M1.68M167K301K215K278K367K515K653K777K437K437K486K534K874K893K786K834K1.01M
Property, Plant & Equipment110K129K148K110K125K77K86K96K106K109K98K30K000000070K
Fixed Asset Turnover--------------------
Goodwill00000000000000000000
Intangible Assets00000000000000000000
Long-Term Investments00000000000000000000
Other Non-Current Assets2M2.06M1.53M57K176K138K192K271K409K544K679K407K437K486K534K874K893K786K834K936K
Total Assets67.22M82.78M97.09M107.78M47.46M61.56M17.95M26.08M32.02M38.98M47.88M31.18M36.71M42M45.13M39.72M41.3M43.31M47.39M52.89M
Asset Turnover--------------------
Asset Growth %41.64%34.47%441.01%313.31%48.23%57.93%-62.52%-16.37%-12.78%-7.18%6.1%-21.49%-11.13%-3.02%-4.77%-24.9%-27.62%-29.28%108.49%86.81%
Total Current Liabilities23.65M20.75M12.99M9.17M9.03M9.08M8.58M9.12M3.33M3.67M7.47M6.3M3.76M3.18M2.29M1.51M1.26M1.76M3.74M2.98M
Accounts Payable13.08M9.99M5.49M5.3M5.02M4.88M5.16M5.28M1.69M1.42M5.35M3.01M1.34M1.15M1.19M698K576K946K2.33M985K
Days Payables Outstanding54.65K-15.82K29.2K31.32K34.28K46.17K48K31.67K15.72K51.96K128.19K-------16.94K7.67K
Short-Term Debt00000000000000000000
Deferred Revenue (Current)00000000000000000000
Other Current Liabilities10.56M10.76M7.5M934K1.25M1.55M1.22M1.03M813K947K00320K890K642K454K359K000
Current Ratio2.75x3.88x7.34x11.74x5.22x6.76x2.06x2.82x9.45x10.45x6.30x4.88x9.65x13.06x19.45x25.67x32.17x24.19x12.45x17.42x
Quick Ratio2.75x3.88x7.34x11.74x5.22x6.76x2.06x2.82x9.45x10.45x6.30x4.88x9.65x13.06x19.45x25.67x32.17x24.19x12.45x17.42x
Cash Conversion Cycle--------------------
Total Non-Current Liabilities1.48M1.04M000000000000000000
Long-Term Debt00000000000000000000
Capital Lease Obligations00000000000000000000
Deferred Tax Liabilities00000000000000000000
Other Non-Current Liabilities1.48M1.04M000000000000000000
Total Liabilities25.12M21.79M12.99M9.17M9.03M9.08M8.58M9.12M3.33M3.67M7.47M6.3M3.76M3.18M2.29M1.51M1.26M1.76M3.74M2.98M
Total Debt00000000000000000000
Net Debt-58.22M-76.96M-93.41M-106.14M-45.86M-22.24M-16.36M-24.5M-10.63M-11.96M-21.14M-20.44M-35.9M-41.1M-44.05M-38.55M-40.03M-42.04M-45.66M-50.8M
Debt / Equity--------------------
Debt / EBITDA--------------------
Net Debt / EBITDA--------------------
Interest Coverage----------68.59x----823.17x--201.33x-48.43x-79.55x--
Total Equity42.1M60.99M84.1M98.61M38.43M52.48M9.37M16.96M28.68M35.31M40.41M24.88M32.95M38.82M42.84M38.21M40.05M41.55M43.65M49.91M
Equity Growth %9.56%16.22%797.9%481.41%33.96%48.61%-76.82%-31.84%-12.94%-9.03%-5.67%-34.87%-17.73%-6.57%-1.87%-23.45%-26.78%-29.56%114.82%100.62%
Book Value per Share0.240.414.738.403.378.215.079.1918.4624.3026.6829.5639.2146.2156.5864.7167.8370.4076.6391.72
Total Shareholders' Equity42.1M60.99M84.1M98.61M38.43M52.48M9.37M16.96M28.68M35.31M40.41M24.88M32.95M38.82M42.84M38.21M40.05M41.55M43.65M49.91M
Common Stock14K13K13K12K6K6K1K36K36K36K36K21K21K21K21K15K15K15K15K14K
Retained Earnings-245.51M-223.37M-198.59M-180.9M-169.65M-154M-146.84M-138.45M-125.94M-118.52M-112.65M-102.69M-93.8M-87.04M-82.17M-78.77M-75.73M-73.17M-69.82M-62.07M
Treasury Stock00000000000000000000
Accumulated OCI-4K3K-6K0011K1K-7K-2K4K-5K1K00000-43.31M-47.39M-52.89M
Minority Interest00000000000000000000